First Multiple Sclerosis Biosimilar Approved
(MedPage Today) -- The first biosimilar for multiple sclerosis (MS) was approved, the FDA announced late Thursday.
Natalizumab-sztn (Tyruko) was approved as a biosimilar to natalizumab (Tysabri) injection to treat clinically isolated syndrome... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - August 25, 2023 Category: Gastroenterology Source Type: news
FDA Approves Tyruko (natalizumab-sztn), a Biosimilar to Tysabri
August 24, 2023 -- The U.S. Food and Drug Administration today approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection for the treatment of adults with relapsing forms of multiple sclerosis (MS). Tyruko, like... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 24, 2023 Category: Drugs & Pharmacology Source Type: news
FDA Approves First Biosimilar to Treat Multiple Sclerosis
FDA has approved the first biosimilar to Tysabri (natalizumab) injection for the treatment of relapsing forms of multiple sclerosis. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 24, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Patients Say Ketogenic Diet Aids Multiple Sclerosis Symptoms
MONDAY, Aug. 21, 2023 -- Patients report that a ketogenic diet (KD) improves multiple sclerosis (MS) symptoms, according to a study published in the August issue of Clinical Nutrition.
Emma Wetmore, from University of Virginia in Charlottesville,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 21, 2023 Category: Pharmaceuticals Source Type: news
3D eye scans at opticians could identify those at risk of Parkinson ’s, study finds
People with high chance of developing disease could be warned up to seven years before symptoms appear, research indicates3D eye scans widely used in high street opticians could help to identify people at high risk of developing Parkinson ’s disease up to seven years before they have symptoms, data has suggested.The finding added to growing evidence that the use of eye scan data could help to detect neurodegenerative diseases and followed recent studies suggesting that the technique could help to identify early signs of Alzheimer ’s, multiple sclerosis and schizophrenia. This emerging field of research, known as “occ...
Source: Guardian Unlimited Science - August 21, 2023 Category: Science Authors: Linda Geddes Science correspondent Tags: Medical research Health Society Science Alzheimer's Diabetes Mental health UK news Source Type: news
Multiple Sclerosis patients may be offered monthly survey which could help doctors determine who will get severe form of condition
One patient who has already benefitted from the Multiple Sclerosis Register is Dominic Shadbolt, 54, from Oxford who began taking part in 2018. Pictured with his wife Claire (Source: the Mail online | Health)
Source: the Mail online | Health - August 21, 2023 Category: Consumer Health News Source Type: news
Multiple Sclerosis sufferers may be offered monthly survey which could help doctors determine who will get severe form of disease
One patient who has already benefitted from the Multiple Sclerosis Register is Dominic Shadbolt, 54, from Oxford who began taking part in 2018. Pictured with his wife Claire (Source: the Mail online | Health)
Source: the Mail online | Health - August 19, 2023 Category: Consumer Health News Source Type: news
Make a tee time with MS4MS and Johns Hopkins to fight multiple sclerosis!
MS4MS (Mission Stadiums for Multiple Sclerosis) is hosting a fundraising event for Johns Hopkins Hospital on Saturday, September 9th, 2023, at Compass Pointe Golf Course in Pasadena, MD. The golf outing will include a day full of golf, food, drinks, and fun! Funds raised from the event... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 17, 2023 Category: Pharmaceuticals Tags: PDT Source Type: news
Fatigue Correlates With Disability in Patients With Relapsing-Remitting MS
MONDAY, Aug. 14, 2023 -- A lower disability rate, better physical condition, and higher daily-living activity predict lower fatigue levels in patients with relapsing-remitting multiple sclerosis (RRMS), according to a study published online July 21... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 14, 2023 Category: Pharmaceuticals Source Type: news
Fatigue Can Plague People With MS. Exercise May Help
WEDNESDAY, Aug. 9, 2023 -- Patients with a type of multiple sclerosis (MS) known as relapsing-remitting MS could have less fatigue if they got more active and were in better physical shape, according to new research.
The study also found that a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 9, 2023 Category: General Medicine Source Type: news
Engineered Probiotic Developed to Treat Multiple Sclerosis
Brigham researchers are working on a new approach to target autoimmunity in the brain leverages designer bacteria to make treatment safer and more effective (Source: BWH News)
Source: BWH News - August 9, 2023 Category: Hospital Management Source Type: news
Morrisville pharma inks deal worth close to $650 million
A pharmaceutical company in Morrisville has secured a deal worth up to nearly $650 million to license its multiple sclerosis treatment outside of North America. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 1, 2023 Category: Pharmaceuticals Authors: Zac Ezzone Source Type: news
Obesity Drugs Don't Make WHO Essential List, MS Drugs Added Obesity Drugs Don't Make WHO Essential List, MS Drugs Added
Obesity drugs will not join the World Health Organization ' s latest essential medicines list, but treatments for diseases, including Ebola and multiple sclerosis will.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 27, 2023 Category: Infectious Diseases Tags: Diabetes & Endocrinology News Source Type: news
2001 to 2020 Saw Shift in Rx for Disease-Modifying Therapy for Multiple Sclerosis
THURSDAY, July 27, 2023 -- Oral disease-modifying therapies (DMTs) predominated new initiations for treatment of multiple sclerosis (MS) in 2020, according to a study published online July 10 in JAMA Neurology.
Mackenzie Henderson, Pharm.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 27, 2023 Category: Pharmaceuticals Source Type: news
Africa: WHO Endorses Landmark Public Health Decisions on Essential Medicines for Multiple Sclerosis
[WHO] Today the World Health Organization (WHO) published the new editions of the Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc) which include important new medicines for the treatment of multiple sclerosis, cancer, infectious diseases, and cardiovascular conditions, among others. The updated Model Lists aim to facilitate greater access to innovative medicines that show clear clinical benefits. These treatments could have a very large public health impact globally without je (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 27, 2023 Category: African Health Tags: Africa External Relations Health and Medicine International Organizations and Africa Source Type: news
